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Introduction
In the heart β-adrenoceptor (AR) signaling is essential for the "fight-or-flight" response mediated by the sympathetic nervous system through norepinephrine and epinephrine, acting on cardiac myocytes mainly via β-AR. In rodents, activation of β 1 -AR largely accounts for the increase in cardiac contractility (inotropy), frequency (chronotropy) and relaxation velocity (lusitropy) (Brodde et al., 2001; Rockman et al., 2002; Xiang and Kobilka, 2003; El-Armouche and Eschenhagen, 2009 ). β-AR stimulation leads via stimulating G-proteins (Gs), activation of adenylyl cyclases (AC) and production of cyclic adenosine-3', 5'-monophosphate (cAMP) to the activation of the cAMP-dependent protein kinase A (PKA). This results in the phosphorylation of a set of key regulatory proteins that control the excitation-contraction coupling cycle, such as sarcolemmal L-type Ca 2+ channels (LTCC), sarcoplasmic ryanodine receptors (RyR2) and phospholamban (PLB), which together coordinate significant increases in cardiac inotropy, chronotropy, and lusitropy (Rapundalo, 1998; Bers, 2002) .
Transgenic overexpression of β 1 -AR in mice resulted in a higher sensitivity to catecholamines, elevated basal heart rate and contractility in young mice, but heart failure and sudden death during aging (Engelhardt et al., 1999) . In contrast genetic deficiency of the β 1 -AR led to pre-natal death of the majority of the mice, indicating the important role of the receptor during development (Rohrer et al., 1998) . Hearts of the mice that survived were morphologically and functionally not distinguishable from wild-type, including normal heart rate and blood pressure. But as expected, β 1 -AR-KO mice lacked positive inotropic and chronotropic effects of the mixed β 1 -/β 2 -AR agonist isoprenaline, substantiating the dominant role of this receptor subtype. β 2 -AR-mediated hypotensive reaction was conserved. Heart rate in β 1 -AR-deficient mice was regulated by parasympathetic nervous system and interestingly, cardiovascular function during exercise (e.g. treadmill experiments) did not differ from wild-JPET #210898 6 type mice (Rohrer et al., 1998) . These findings underscore the necessity and utility of studying β 1 -AR functions through acute loss-of-function approaches in vitro and in vivo.
In this study we assessed functional consequences of acute genetic β 1 -AR silencing in an experimental setup of 3-dimensional engineered heart tissue (EHT). EHTs represent threedimensional heart-tissue-like cardiac myocyte cultures that allow the determination of standard parameters of contractile function under isometric conditions. They provide cells with a relatively physiological three-dimensional environment are stable for weeks and are easy to infect with AAV with high efficiency (Hansen et al., 2010; Cattin et al., 2013) .
Contrary to our expectations, β 1 -AR knockdown was associated with higher basal and β-AR isoprenaline mediated force generation. Large scale gene expression analysis by microarray technology identified almost 280 differentially regulated genes attributed to specific β 1 -AR knockdown rather than unspecific AAV or RNAi effects. No obvious off-target effects explaining our results or compensatory changes in e.g. β 2 -AR could be identified.
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Cardiomyocytes and analysis
Neonatal rat cardiac myocytes (NRCM) were isolated from 1-3 day old neonates (Wistar and Lewis rats of mixed sex) by a fractionated DNase/Trypsin digestion protocol as described earlier (El-Armouche et al., 2003 
Generation of adeno-associated viral vectors
An shRNA expression cassette containing the H1-promoter sequence and the specific shB1/shCTR sequence was amplified by PCR using specific primers to insert MluI restriction sites at both ends. After restriction with MluI shRNA expression cassette was subcloned into pdsAAV-CMV-eGFP vector that was linearized with MluI before. Recombinant AAV JPET #210898 genome is depicted in Supplemental Fig. 2A . Production, purification, and titration of high titer adeno-associated viral vectors of serotype 6 (AAV-6) had been described before (Raake et al., 2012) . Virus titers were about 1.5x10 12 virus genomes/ml.
Engineered heart tissue and analysis
Fibrin-based engineered heart tissues (EHT) from neonatal rat heart cells were generated and cultured as previously described (Hansen et al., 2010 transduced with AAV-6 encoding shB1-or shCTR (10 5 virus genomes/cell), which was directly applied to the reconstitution mix. EHTs were cultured up to 21 days in culture medium (DMEM, 10% horse serum, 2% chick embryo extract, 1% penicillin/streptomycin, insulin 10 µg/ml, 33 µg/ml aprotinin). Contraction measurements were performed by video optical recording on day 6, 8, 10, 12, 14, 16 and 18 as previously described (Hansen et al., 2010 
Genexpression analysis -microarray data
This article has not been copyedited and formatted. The final version may differ from this version. For microarray analysis the total RNA from EHT was purified by DNase digestion (RNeasy Mini Kit) and further converted to biotinylated cRNA via in vitro-transcription according to the manufacturer's protocol (Illumina® TotalPrep™ RNA Amplification Kits).
Subsequently cRNA samples (n = 6) from each experimental group were hybridized on Illumina RatRef-12 Expression BeadChip Array containing 21910 probes (Illumina BD-27-302) and were analyzed with a BeadArray Reader and BeadScan software (Illumina). Gene expression levels were calculated using GenomeStudio software 2010 (Illumina), data were fit to a quantile normalization model and about 21791 expressed genes were identified.
Differentially regulated genes were detected by applying Illumina custom error model, multiple testing correction was performed using Benjamini and Hochberg False Discovery
Rate (Luchtefeld et al., 2011) . Genes with a fold change FC 
Histology and immunochemical analysis
EHTs were analysed by immunofluorescence using confocal imaging. Therefore EHTs 
Statistical analysis
Differences between groups were assessed using Student's t-test, one-way ANOVA or two-way ANOVA. Average data are presented as mean ± SEM. Differences were considered significant when *P < 0.05, **P < 0.01, and ***P < 0.001.
This article has not been copyedited and formatted. The final version may differ from this version. 
Results
AAV6-mediated shRNA expression against β 1 -AR in NRCM and EHTs
We identified one out of three sequences mediating a robust and strong β 1 -AR knockdown in HEK-B1 cells (Supplemental Fig.1 ) and therefore this sequence was used for AAV6-shB1 generation (Supplemental Fig. 2A ) and all further experiments. To establish efficient gene silencing of β 1 -AR, NRCM were transduced with increasing amount of viral genomes per cells 3*10 3 -1*10 5 of either AAV6-shB1 or AVV6-shCTR. After 72 h transduction efficiency was visualized by GFP-epifluorescence (Supplemental Fig. 2B ) and knockdown efficiency was tested on the mRNA level (Supplemental Fig. 2C ). Increasing GFP signals correlated with an increasing reduction in β 1 -AR mRNA by up to 62% compared to AAV6-shCTR.
To study functional consequences of β 1 -AR knockdown we transduced EHTs with 10 5 viral genomes per cell of AAV6-shB1/shCTR. The highest transduction efficiency was achieved when applying virus directly to the EHT reconstitution mixture (data not shown).
GFP-epifluorescence showed a high and constant transduction rate of both viral vectors in EHTs ( Fig. 1A upper panel) . A more detailed immunofluorescence analysis showed predominant co-localization of the GFP signal with the cardiomyocyte-specific marker α-actinin ( Fig. 1A lower panel) , indicating preferential transduction of cardiomyocytes compared to non-myocytes that are also present in EHTs. Accordingly, β 1 -AR mRNA and receptor density were reduced by 62% and 72% (Fig. 1B, C) , respectively, whereas β 2 -AR mRNA ( Fig. 1D ) was not affected, proving selective and robust effectiveness of our knockdown strategy.
Functional consequences of β 1 -AR downregulation in EHTs
This article has not been copyedited and formatted. The final version may differ from this version. Virally transduced EHTs developed properly and were indistinguishable from the nontransduced controls (data not shown). Contractility was analysed regularly over the entire culture period by video-optical recording. Exemplary, the most important parameters measured at day 14 are depicted in Fig. 2 . Beating rate as well as contraction and relaxation times (T1, T2) did not differ from control ( Fig. 2A and B) , but unexpectedly force development ( Fig. 2C ) was higher in β 1 -AR knockdown than in control EHTs (Force at 1.8 mM calcium: 0.19 ± 0.01 mN vs. 0.13 ± 0.01 mN in AAV6-shCTR, P < 0.001). Similarly, the inotropic response to β-adrenergic stimulation with 100 nM isoprenaline (Fig. 2D , measured at low external calcium and electrical stimulation at 2 Hz) was higher (FS increase 72 ± 5% vs. 34 ± 4%, P < 0.001). Results were obtained and reproduced in four different time series with a total number of n=32 (AAV6-shB1) and n=26 (AAV6-shCTR). Concentration response curves for calcium and isoprenaline showed no difference in the sensitivity to external calcium (Supplemental Fig. 3 ) and in the inotropic potency of isoprenaline (Supplemental Fig. 4) . Thus, diametrically opposed to our expectations genetic knockdown of β 1 -AR was associated with higher force generation and larger inotropic responses to isoprenaline.
In order to test whether a functional upregulation of β 2 -AR may have compensated for β 1 -AR downregulation we analysed the chronotropic response to the β 1 /β 2 -AR agonist isoprenaline in the presence and absence of the selective β 2 -adrenergic antagonist ICI 118,551
(100 nM). In the presence of ICI 118,551 the maximal chronotropic effect of isoprenaline was preserved, but the curve was shifted to the right by about half log unit in both groups ( Fig. 3A and B). The shift was significantly less than what is to be expected of a β 2 -AR-mediated effect (two log units (Hoffmann et al., 2004) ), suggesting that the small shift was due to the incomplete selectivity of ICI 118,551 and partial occupancy of β 1 -AR at this concentration.
This article has not been copyedited and formatted. The final version may differ from this version. These results argue against functional upregulation of β 2 -AR, a conclusion which is also supported by the lack of β 2 -AR mRNA regulation (Fig. 1D ).
Genetic consequences of β 1 -AR downregulation in EHTs
To address potential involvement of AAV and/or shRNA-related adverse or off-target effects caused either by viral transduction, shRNA or by β 1 -AR knockdown itself we performed a micro-array gene expression analysis. Results show that virus treatment (AAV6-shCTR compared to nontransduced CTR) did not induce strong changes in the gene expression profile (Fig. 4A ) demonstrating that AAV and/or shRNA-related adverse or offtarget effects have little impact. On the other hand β 1 -AR knockdown resulted in marked differential regulation of genes compared to AAV6-shCTR (Fig 4B) . In particular, analysis of AAV6-shB1 vs. AAV6-shCTR displayed a total number of 277 differentially regulated genes ( Table 1 (for all regulated genes see Supplemental Table 1 ). There was no regulation of prominent β-AR signaling targets, e.g. 
Discussion
Cardiac β 1 -AR play a key role in the regulation of heart function. In this study we assessed functional consequences of subacute genetic β 1 -AR silencing in spontaneously beating and force-generating 3-dimensional EHT. The feasibility of the EHT-system as a test bed for pharmacological (Hansen et al., 2010; Schaaf et al., 2011) (Engelhardt et al., 1999 ) and similar to hearts of patients chronically treated with β-blockers. It seems likely that the phenotype in β 1 -AR knockdown EHTs is the consequence of the altered gene expression program, but direct cause-effect relationships cannot be established with this method.
Because our loss-of-function approach did not achieve complete β 1 -AR depletion, the remaining receptors were likely sufficient for maintaining β 1 -AR inotropic (Fig. 2D ) and chronotropic (Fig. 3B) responses. Indeed, a high receptor reserve has been reported in rat heart compared to human myocardium (Brown et al., 1992) . However, receptor reserve does not explain the significant increase in basal contractility and increased positive inotropic response. A compensatory upregulation of β 2 -AR as a mechanism superimposing β 1 -AR downregulation was ruled out by demonstrating unaffected β 2 -AR mRNA levels and also functionally with the selective β 2 -AR antagonist ICI 118,551 ( Fig. 1D and 3B ). This is consistent with findings in β 1 -AR-KO mice (Rohrer et al., 1998) . In addition gene expression analysis did not indicate differential regulation of other elements of the β-AR signaling cascade including β-AR receptor kinase 1, SR-calcium ATPase, phospholamban or stimulatory/inhibitory G-protein alpha subunit. Thus, no obvious candidate was identified that explains the increased force and response to isoprenaline.
In principle, the phenotype could be just an artefact, e.g. by off-target effects of the si/shRNA sequence or the expression vector itself. This cannot be completely excluded, but seems unlikely for two reasons. First, nonspecific effects almost always result in decreases of contractile force and isoprenaline responses in EHTs up to now. Second, care was taken to minimize the chance for off-target effects. A single mismatch can result in the complete loss of function of the relevant siRNA sequence (Brummelkamp et al., 2002; Schubert et al., 2005) or in the loss of specificity towards the target mRNA (Agrawal et al., 2003) , and thereby siRNAs may cross-react with targets of limited sequence similarity (Saxena et al., 2003) . In this context, direct silencing of non-targeted genes containing as few as eleven contiguous nucleotides of identity to the siRNA can occur (Jackson et al., 2003) . Besides sequence identity, off-targeting can be associated with the matches between parts of the 3' untranslated region (UTR) and with the seed region of the antisense strand of the siRNA (Birmingham et al., 2006) . Therefore, minimization of those unwanted effects is essential for siRNA design (Qiu et al., 2005; Jackson et al., 2006) . In this study, we used "scrambled" control sequences protective effects in the heart. Interestingly, β-AR blockade has been suggested to provide an example of α 1 -AR "gain-of-function" (Jensen et al., 2010) . In adult ventricular mouse cardiomyocytes, adrenaline abolished ERK signaling via β-ARs, whereas it augmented ERK signaling via α 1 -AR -which was cardioprotective -under conditions of β-AR blockade (Huang et al., 2007; Jensen et al., 2010) . This indicates that β-AR blockade may mediate favourable effects by augmenting beneficial α 1 -AR signaling. Thus highly efficient β 1 -AR downregulation knockdown may switch signal transduction pathways towards beneficial signaling profiles and thereby to an improved phenotype with greater contractility in our model. Our in vitro β 1 -AR loss of function model clearly differs from β 1 -AR KO mice in which isoprenaline had simply no effect (Rohrer et al., 1996) . It shares, however, the observation that loss of β 1 -AR is compatible with apparently normal cardiac function. β 1 -KO mice displayed normal basal heart rate and maximal exercise capacity (treadmill experiment), indicating compensatory mechanisms to maintain normal cardiac function and regulation.
Even the total loss of β 1 -AR and β 2 -AR in β 1 /β 2 -AR double KO mice was accompanied by normal basal heart rate, normal blood pressure and normal exercise capacities (Rohrer et al., 1999) . Moreover, β 1 /β 2 -AR double KO showed protection from chronic pressure overloadinduced cardiac hypertrophy and fibrosis. Importantly, this was associated with preserved cardiac function (Kiriazis et al., 2008) . This indicates impressively that chronic β 1 /β 2 -AR deficiency rather than chronic overstimulation of the β-AR system is associated with beneficial effects (Lee et al., 2008) .
Our surprising finding also opens future avenues for in vivo cardiac β-AR research.
Techniques to monitor and image the murine cardiovascular system have been developed enormously in the last decade (Ram et al., 2011; Moran et al., 2013) . Thus re-evaluation of β 1 -AR and β 1 /β 2 -AR double KO with e. g. high-resolution Doppler techniques, strain rate-, and four-dimensional echocardiography as well as micro CT and micro MRI should allow new insights into the structural and functional characteristics. This may help to decipher the differential roles of β 1 -AR and β 2 -AR. Also, conditional cardiac-specific β-AR KO models (Cre-Lox-, Tet-or MerCreMer-System) may help to circumvent the high intrauterine mortality and compensational mechanism. Moreover, crossing of β 1 -AR KO with dopamine β-hydroxylase KO mice which are devoid of endogenous norepinephrine and epinephrine (Rapacciuolo et al., 2001) would be very useful to delineate the role of the sympathetic nervous system for the outcome.
This article has not been copyedited and formatted. The final version may differ from this version. In conclusion, our study emphasizes the overall complexity regarding β-AR regulation and underscores the necessity of studying β-AR functions through acute loss-of-function approaches in vivo in order to understand the mechanisms more properly. In future this may help to develop new and better generations of β-blockers with fewer side effects.
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